Endoscopy 2004; 36(10): 893-897
DOI: 10.1055/s-2004-825857
Original Article
© Georg Thieme Verlag Stuttgart · New York

Photodynamic Therapy in Normal Pig Stomach: Protective Effect of Octreotide

E.  Mallas1 , G.  Karamanolis1 , M.  Zissis1 , E.  Karvouni2 , G.  Kostopanagiotou3 , M.  Macropoulou4 , A.  A.  Serafetinidis4 , S.  Ladas5 , S.  A.  Raptis5
  • 1 Second Surgical Department, Endoscopy Unit, Athens Medical School, Aretaieion University Hospital, Athens, Greece
  • 2Pathology Department, Athens Medical School, Aretaieion University Hospital, Athens, Greece
  • 3Anesthesia Department, Athens Medical School, Aretaieion University Hospital, Athens, Greece
  • 4Department of Physics, National Technical University of Athens, Athens, Greece
  • 5Second Department of Internal Medicine, Athens Medical School, Evangelismos Hospital, Athens, Greece
Further Information

Publication History

Submitted 20 June 2004

Accepted after Revision 13 July 2004

Publication Date:
28 September 2004 (online)

Background and Study Aims: Many factors, such as oxygen and vasculature, are involved in the cytotoxic effect of photodynamic therapy (PDT). It is known that somatostatin and its analog octreotide decrease the splanchnic blood flow and have multiple inhibitory effects in different functions of the peptic system. The aim of this experimental study was to assess the effect of octreotide administration on PDT outcome in normal pig stomach.
Methods: 28 healthy pigs, randomly assigned to two groups, A and B, were studied. Pigs in both groups were sensitized with 0.3 mg/kg intravenous meta-tetra (hydroxyphenyl) chlorin (m-THPC), and 48 hours later light of wavelength 650 nm was delivered from a 50-mW diode laser for 300 s (energy fluence 15 J/cm2) through a gastroscope to the gastric mucosa. Group A underwent PDT without octreotide and group B had PDT with administration of octreotide. At 72 h after light delivery, all the animals were sacrificed for macroscopic and histological evaluation of the irradiated site.
Results: The macroscopic images and the histology of the stomach PDT lesions (inflammation, ulceration, necrosis) showed significantly less severity in the group of animals with octreotide injection (group B). In this group, full-thickness necrosis was observed in 28.5 %, compared with over 71.4 % in group A; this was statistically significant (P < 0.05).
Conclusion: Octreotide may have a modulating effect on m-TPHC PDT in normal gastric tissue in pigs, probably due to alterations of hemodynamics in the stomach and to suppression of the inflammatory process.

References

  • 1 Dougherty T J. An update on photodynamic therapy applications.  J Clin Laser Med Surg. 2002;  20 3-7
  • 2 Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer.  Lancet Oncol. 2000;  1 212-219
  • 3 Moore J V, West C ML, Whitehurst C. The biology of photodynamic therapy.  Phys Med Biol. 1997;  42 913-935
  • 4 Bown S G, Lovat L B. The biology of photodynamic therapy in the gastrointestinal tract.  Gastrointest Endosc Clin N Am. 2000;  10 533-550
  • 5 Barr H, Tralau C J, MacRobert A J. et al . Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation.  Br J Cancer. 1987;  56 111-118
  • 6 Mlkvy P, Messmann H, Pauer M. et al . Distribution and photodynamic effects of meso-tetrahydroxyphenylchlorin (m-THPC) in the pancreas and the adjacent tissues in the Syrian golden hamster.  Br J Cancer. 1996;  73 1473-1479
  • 7 Ris H B, Altermatt H J, Nachbur B. et al . Effect of drug-light interval on photodynamic therapy with meta-tetrahydroxyphenylchlorin in malignant mesothelioma.  Int J Cancer. 1993;  53 141-146
  • 8 Parmar H, Bogden A, Mollard M. et al . Somatostatin and somatostatin analogues in oncology.  Cancer Treat Rev. 1989;  16 95-115
  • 9 Harris A G. Somatostatin and somatostatin analogues: pharmacokinetics and pharmacodynamic effects.  Gut. 1994;  35 (3 Suppl) S1-4
  • 10 Avgerinos A, Armonis A, Raptis S. Somatostatin and octreotide in the management of acute variceal hemorrhage.  Hepatogastroenterology. 1995;  42 145-150
  • 11 Grahn M F, Giger A, McGuinness A. et al . mTHPC polymer conjugates: the in vivo photodynamic activity of four candidate compounds.  Lasers Med Sci. 1999;  14 40-46
  • 12 Lamberts S WJ, Van der Lely J, de Herder W W. et al . Drug therapy: octreotide.  N Engl J Med. 1996;  334 246-254
  • 13 Mallas E, Zissis M, Serafetinidis A. et al . Photodynamic therapy in normal rat stomach. Effect of octreotide [abstract].  Digestion. 1998;  59 Suppl 3 45
  • 14 Bown S G, Millson C E. Photodynamic therapy in gastroenterology.  Gut. 1997;  41 5-7
  • 15 Bown S G, Rogowska A Z. New photosensitizers for photodynamic therapy in gastroenterology.  Can J Gastroenterol. 1999;  13 389-392
  • 16 Tarnasky P R, Kovacs T O, Leung F W. et al . Octreotide decreases canine gastric mucosal blood flow: a controlled assessment by endoscopic reflectance spectrophotometry.  Gastrointest Endosc. 1994;  40 56-61
  • 17 Jenkins S A, Baxter J N, Corbett W A. et al . The effects of a somatostatin analogue 201-995 on hepatic hemodynamics in the cirrhotic rat.  Br J Surg. 1985;  72 864-867
  • 18 Jenkins S A, Baxter J N, Corbett W A. et al . Effects of a somatostatin analogue 201-995 on hepatic hemodynamics in the pig and on intravariceal pressure in man.  Br J Surg. 1985;  72 1009-1012
  • 19 Kubba A K, Dallal H, Haydon G H. et al . The effect of octreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man.  Am J Gastroenterol. 1999;  94 1077-1082
  • 20 Scheiman J M, Tillner A, Pohl T. et al . Reduction of non-steroidal anti-inflammatory drug induced gastric injury and leukocyte endothelial adhesion by octreotide.  Gut. 1997;  40 720-725

E. Mallas, M. D.

54 Vas. Sofias Avenue · 11528 Athens · Greece

Fax: + 30-210-7252605 ·

Email: gkfarsal@hol.gr

    >